121 related articles for article (PubMed ID: 32767498)
1. Editorial Comment from Dr Tsuzuki to Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis.
Tsuzuki T
Int J Urol; 2020 Sep; 27(9):798-799. PubMed ID: 32767498
[No Abstract] [Full Text] [Related]
2. Editorial Comment from Dr Kato to Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis.
Kato T
Int J Urol; 2020 Sep; 27(9):797-798. PubMed ID: 32741002
[No Abstract] [Full Text] [Related]
3. Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis.
Obeng RC; Arnold RS; Ogan K; Master VA; Pattaras JG; Petros JA; Osunkoya AO
Int J Urol; 2020 Sep; 27(9):790-797. PubMed ID: 32638444
[TBL] [Abstract][Full Text] [Related]
4. Editorial Comment from Dr Numakura to Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults: Diagnosis using immunostaining of transcription factor E3 and fluorescence in situ hybridization analysis.
Numakura K
Int J Urol; 2016 Feb; 23(2):147. PubMed ID: 26603520
[No Abstract] [Full Text] [Related]
5. Editorial Comment from Dr Komai to Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults: Diagnosis using immunostaining of transcription factor E3 and fluorescence in situ hybridization analysis.
Komai Y
Int J Urol; 2016 Feb; 23(2):146. PubMed ID: 26603380
[No Abstract] [Full Text] [Related]
6. [Intratumoral heterogeneity in renal cell carcinoma. Molecular basis and translational implications].
Höfflin R; Roth W; Sültmann H; Grüllich C; Hatiboglu G; Nyarangi-Dix J; Schönberg G; Teber D; Hadaschik B; Pahernik S; Hohenfellner M; Duensing S
Urologe A; 2015 Jun; 54(6):800-3. PubMed ID: 25758237
[TBL] [Abstract][Full Text] [Related]
7. Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology.
Sanfrancesco JM; Cheng L
Crit Rev Oncol Hematol; 2017 Nov; 119():23-28. PubMed ID: 29065981
[TBL] [Abstract][Full Text] [Related]
8. [Molecular biology of renal cancer: bases for genetic directed therapy in advanced disease].
Maroto Rey JP; Cillán Narvaez E
Arch Esp Urol; 2013 Jun; 66(5):517-23. PubMed ID: 23793769
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization.
Moch H; Schraml P; Bubendorf L; Richter J; Gasser TC; Mihatsch MJ; Sauter G
Cancer Res; 1998 Jun; 58(11):2304-9. PubMed ID: 9622063
[TBL] [Abstract][Full Text] [Related]
10. Kidney cancer: Intratumoral differences analysed.
Payton S
Nat Rev Urol; 2014 Mar; 11(3):127. PubMed ID: 24567088
[No Abstract] [Full Text] [Related]
11. A clearer view of the molecular complexity of clear cell renal cell carcinoma.
Frew IJ; Moch H
Annu Rev Pathol; 2015; 10():263-89. PubMed ID: 25387056
[TBL] [Abstract][Full Text] [Related]
12. Editorial comment to molecular pathology of chromophobe renal cell carcinoma: a review.
Osunkoya AO
Int J Urol; 2010 Jul; 17(7):600-1. PubMed ID: 20590943
[No Abstract] [Full Text] [Related]
13. Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra- and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneity.
Sanfrancesco JM; Eble JN; Grignon DJ; Wang M; Zhang S; Sundaram CP; Idrees MT; Pili R; Kouba E; Cheng L
Mol Carcinog; 2017 Nov; 56(11):2527-2537. PubMed ID: 28667776
[TBL] [Abstract][Full Text] [Related]
14. Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma.
Wei X; Choudhury Y; Lim WK; Anema J; Kahnoski RJ; Lane B; Ludlow J; Takahashi M; Kanayama HO; Belldegrun A; Kim HL; Rogers C; Nicol D; Teh BT; Tan MH
Sci Rep; 2017 Aug; 7(1):7342. PubMed ID: 28779136
[TBL] [Abstract][Full Text] [Related]
15. Dissecting LncRNA Roles in Renal Cell Carcinoma Metastasis and Characterizing Genomic Heterogeneity by Single-Cell RNA-seq.
Li X; Meng X; Wei C; Zhou Y; Chen H; Huang H; Chen M
Mol Cancer Res; 2018 Dec; 16(12):1879-1888. PubMed ID: 30082482
[TBL] [Abstract][Full Text] [Related]
16. Assessing genetic heterogeneity of renal cell tumors.
Mirghomizadeh F; Kupka S; Blin N
Anticancer Res; 1999; 19(2C):1467-70. PubMed ID: 10365125
[TBL] [Abstract][Full Text] [Related]
17. Editorial Comment on: Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Staehler M
Eur Urol; 2007 Oct; 52(4):1155. PubMed ID: 17287072
[No Abstract] [Full Text] [Related]
18. Editorial comment.
Russo P
Urology; 2011 Apr; 77(4):847-8. PubMed ID: 21477710
[No Abstract] [Full Text] [Related]
19. Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma.
Sanjmyatav J; Junker K; Matthes S; Muehr M; Sava D; Sternal M; Wessendorf S; Kreuz M; Gajda M; Wunderlich H; Schwaenen C
J Urol; 2011 Nov; 186(5):2078-83. PubMed ID: 21944119
[TBL] [Abstract][Full Text] [Related]
20. Genomics and epigenomics of clear cell renal cell carcinoma: recent developments and potential applications.
Rydzanicz M; Wrzesiński T; Bluyssen HA; Wesoły J
Cancer Lett; 2013 Dec; 341(2):111-26. PubMed ID: 23933176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
